These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2522991)

  • 1. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
    Björk L; Höök BB; Nelson DL; Andén NE; Hacksell U
    J Med Chem; 1989 Apr; 32(4):779-83. PubMed ID: 2522991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U
    J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41): two novel 5-HT1A receptor agonists.
    Yu H; Liu Y; Hacksell U; Lewander T
    Eur J Pharmacol; 1993 Jan; 231(1):69-76. PubMed ID: 8444282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
    J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors.
    Björk L; Mellin C; Hacksell U; Andén NE
    Eur J Pharmacol; 1987 Nov; 143(1):55-63. PubMed ID: 2961582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist.
    Hillver SE; Björk L; Li YL; Svensson B; Ross S; Andén NE; Hacksell U
    J Med Chem; 1990 Jun; 33(6):1541-4. PubMed ID: 2140413
    [No Abstract]   [Full Text] [Related]  

  • 9. (R)- and (S)-5-hydroxy-2-(dipropylamino)tetralin (5-OH DPAT): assessment of optical purities and dopaminergic activities.
    Karlsson A; Björk L; Pettersson C; Andén NE; Hacksell U
    Chirality; 1990; 2(2):90-5. PubMed ID: 1976017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.
    Ahlenius S; Hillegaart V; Wijkström A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):551-6. PubMed ID: 2570361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C; Liu Y; Hacksell U; Björk L; Andén NE
    Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167
    [No Abstract]   [Full Text] [Related]  

  • 12. A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin.
    Mellin C; Vallgårda J; Nelson DL; Björk L; Yu H; Andén NE; Csöregh I; Arvidsson LE; Hacksell U
    J Med Chem; 1991 Feb; 34(2):497-510. PubMed ID: 1995871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
    Björk L; Cornfield LJ; Nelson DL; Hillver SE; Andén NE; Lewander T; Hacksell U
    J Pharmacol Exp Ther; 1991 Jul; 258(1):58-65. PubMed ID: 1830099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
    J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo.
    Hjorth S; Magnusson T
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):463-71. PubMed ID: 2469021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (R)- and (S)-5,6,7,8-tetrahydro-1-hydroxy-N,N-dipropyl-9H-benzocyclohepten- 8-ylamine. Stereoselective interactions with 5-HT1A receptors in the brain.
    Liu Y; Mellin C; Björk L; Svensson B; Csöregh I; Helander A; Kenne L; Andén NE; Hacksell U
    J Med Chem; 1989 Oct; 32(10):2311-8. PubMed ID: 2795604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivatives of 2-(dipropylamino)tetralin: effect of the C8-substituent on the interaction with 5-HT1A receptors.
    Liu Y; Yu H; Svensson BE; Cortizo L; Lewander T; Hacksell U
    J Med Chem; 1993 Dec; 36(26):4221-9. PubMed ID: 7506312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA
    J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S; Sharp T; Hacksell U
    Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.